Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
about
Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milkA tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichmentAn alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sitesHuman tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodiesTargeting ECM Disrupts Cancer ProgressionAntibody, T-cell and dendritic cell immunotherapy for malignant brain tumorsThe evolution of tenascins and fibronectinTenascin-C: Form versus functionIdentification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibodyA pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.Carcinomatous meningitis: antibody-guided therapy with I-131 HMFG1.Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers.Matricellular proteins in the trabecular meshwork: review and update.Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach.Experimental approaches for the treatment of malignant gliomas.Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacityGlycoproteomic analysis of glioblastoma stem cell differentiation.A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices.Tenascins and the importance of adhesion modulation.Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarraysTenascin: cDNA cloning and induction by TGF-beta.Tenascin C in metastasis: A view from the invasive frontTenascin-C in primary Merkel cell carcinoma.Melanoma Cell Invasive and Metastatic Potential Correlates with Endothelial Cell Reorganization and Tenascin ExpressionTargeted radiotherapy of brain tumours.Enhanced expression of neural cell adhesion molecules and tenascin (cytotactin) during wound healing.Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin IITumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects.The Presence and Anti-HIV-1 Function of Tenascin C in Breast Milk and Genital Fluids.Immunotherapy of malignant brain tumors.Hexabrachion proteins in embryonic chicken tissues and human tumorsTenascin/hexabrachion in human skin: biochemical identification and localization by light and electron microscopyInduction of tenascin in healing wounds.Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactionsAn instructive role for the interstitial matrix in tissue patterning: tissue segregation and intercellular invasion.Localization during development of alternatively spliced forms of cytotactin mRNA by in situ hybridization.Expression and degeneration of tenascin-C in human lung cancersIdentification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues.Tenascin promotes cerebellar granule cell migration and neurite outgrowth by different domains in the fibronectin type III repeats.
P2860
Q24598653-153B1C64-FCB0-47C7-A110-0A84279BC6F2Q24618342-27328CB8-8C3D-405A-A426-203319E849A8Q24623439-325718A3-7852-4A32-9A13-DDE67729A3A4Q24633292-2DE2374E-4175-47D6-90EF-605D90703F59Q26779300-B0C5D8A0-EB79-4C13-9C65-62D528610FBCQ27011298-EDE7E694-6A91-4E07-BF3D-9236752B8FE4Q27013888-42001659-3F89-4A08-9171-EABD4C780E61Q27023815-D9CE2606-E5BA-410F-900D-ED375D54100CQ30700459-AB0ACD9D-FCD8-4FF4-9C1B-055901C27DC0Q33378699-DC687E86-823B-428E-BC00-03BE67955EACQ33589456-23E2FFA4-A235-42DB-945F-916A02E9CFB8Q33705446-2AD436C0-9866-403D-AE7B-226A28747E7AQ33801657-D2BD1C5D-790E-4596-B0D4-EB2F8235DD3EQ33820048-31B55AEB-50F4-439B-ACB2-1A6980ACE657Q33835228-5675C201-B28B-4D01-B518-195503BC0823Q34127138-08C2FD50-D453-440F-A6D5-2980A7B90F13Q34304376-2F0CFDD5-6FAB-40F4-A673-704E82753011Q34474236-5BCB5CF0-37FB-4D3B-8E3B-DA90D6C2493AQ34961648-2CBD612C-B543-484E-8A62-D2FDF0F040AFQ35006502-29BC39CA-4AF3-4386-8960-09E58DC52186Q35060849-716D463C-2137-4C08-A60B-0EEBCEC50D69Q35112653-4BE9FCF5-3526-4451-A5DD-E09618B1155AQ35577928-76165715-4E74-4BC3-8321-FE7CADD76A16Q35588420-30D73EFA-62EF-4403-BBAB-4A20E6974C2DQ35741881-92AFFF4F-C3B6-4A81-96C8-4E1CE040ECA7Q35745251-DF6A08D8-17B6-49BD-AC45-968973F97A59Q35830730-56252D83-F66C-4472-BE78-93F63ACB9EFDQ35831907-2A696501-D3C3-42A5-9531-10CE5B43721AQ35951631-7EA229E0-0739-4610-924E-37AD74DD1437Q36018536-54BB9371-8EDD-4D1D-90B6-CE8DC737B6E7Q36162929-B4D7D336-FC35-4560-B989-A4EC411804BFQ36217535-04D54D7E-419B-44F2-A36C-9CE8D9817F59Q36220814-83F46D91-F994-4C1B-B70D-592B507A6B03Q36220912-3F791990-3721-4D95-B817-FA60A4702A22Q36220933-E39936B0-2246-43A6-B79B-19DFF32A4A5AQ36222805-231843EF-6BE0-4686-9E13-C74F92281A5EQ36223301-974279B9-63F7-48E3-A2FF-D55713A75B6BQ36294957-65DBA348-23E6-47CE-A700-B4BFD1A9DA47Q36529914-505B706C-E6F2-40B4-9320-9E241DB6ED8AQ36531142-91764934-3E0F-42F3-8F48-28AB4AAE52BE
P2860
Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh-hant
name
Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
@en
Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
@nl
type
label
Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
@en
Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
@nl
prefLabel
Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
@en
Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
@nl
P2093
P1433
P1476
Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody
@en
P2093
Bourdon MA
Furthmayr H
Matthews TJ
Wikstrand CJ
P304
P407
P577
1983-06-01T00:00:00Z